4 结论
随着肝脏疾病蛋白质组学研究的不断深入，将会不断产生新的和更权威的具有诊断潜能的生物分子靶标，通过分析和监视相应蛋白质的变化，能及时掌握患者病程特点和进展趋势，对于患者的个体化治疗具有重要价值；更有意义的是，早期发现这些预警分子不仅可以有助于临床诊断、治疗肝脏疾病，甚至可以发现患病的高危人群，及早采取相应措施，从而做到防患于未然。
5 参考文献
1 Wasinger VC, Cordwell SJ, Cerepa-Poljak A, et al. Progress withgene-product mapping of the Mollicutes: Mycoplasma genitalium.Electrophoresis 1995;16:1090-1094
2 Tyers M, Mann M. From genomics to proteomics. Nature2003;422:193-197
3 Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis.World J Gastroenterol 2001;7:445-454
4 Parent R, Beretta L. Proteomics in the study of liver pathology. JHepatol. 2005;43:177-183
5 Strey CW, Winters MS, Markiewski MM, et al. Partial hepatectomyinduced liver proteome changes in mice. Proteomics2005;5:318-325
6 Marko-Varga G, Berglund M, Malmstrom J, et al. Targeting hepatocytesfrom liver tissue by laser capture microdissection and proteomicsexpression profiling. Electrophoresis 2003;24:3800-3805
7 Kristensen DB, Kawada N, Imamura K, et al. Proteome analysis ofrat hepatic stellate cells. Hepatology 2000;32:268-277
8 Da Cruz S, Xenarios I, Langridge J, et al. Proteomic analysis of themouse liver mitochondrial inner membrane. J Biol Chem 2003;278:41566-41571
9 Wu CC, MacCoss MJ, Mardones G, et al. Organellar proteomicsreveals Golgi arginine dimethylation. Mol Biol Cell2004;15:2907-2919
10 黄耀煊. 肝病分子生物学[M]. 福州：福建科学技术出版社，2003：274-300
11 He QY, Lau GK, Zhou Y, et al. Serum biomarkers of hepatitis Bvirus infected liver inflammation: a proteomic study. Proteomics2003;3:666-674
12 Fang CY, Yi ZG, Liu F, et al. Proteome analysis of human livercarcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.Proteomics 2006;6:519-527
13 Poon TC, Hui AY, Chan HL, et al. Prediction of liver fibrosis andcirrhosis in chronic Hepatitis B infection by serum proteomic fingerprinting:a pilot study. Clin Chem 2005;51:328-335
14 Henkel C, Roderfeld M, Weiskirchen R, et al. Identification offibrosis-relevant proteins using DIGE (difference in gel electrophoresis)in different models of hepatic fibrosis. Z Gastroenterol2005;43:23-29
15 Liotta LA , Kohn EC. The microenvironment of the tumour hostinterface. Nature 2001;411:375-379
16 Liang RC, Neo JC, Lo SL, et al. Proteome database of hepatocellularcarcinoma. J Chromatogr B Analyt Technol Biomed Life Sci2002;771:303-328
17 Seow TK, Ong SE, Liang RC, et al. Two-dimensional electrophoresismap of the human hepatocelular carcinoma cell line, HCC-M,and identification of the separated proteins by mass spectrometry.Electrophoresis 2000;21:1787-1813
18 Yu LR, Zeng R, Shao XX et al. Identification of differentially expressedproteins between human hepatoma and normal liver celllines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000;21:3058-3068
19 Poon TC, Johnson PJ. Proteome analysis and its impact on thediscovery of serological tumormarkers. Clin Chim Acta 2001;313:231-239
20 Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written inblood. Nature 2003;425:905
21 王征，阮幼冰，官阳，等. 肝细胞癌患者血清蛋白质组成分的双向凝胶电泳-飞行时间质谱分析[J]. 中华病理学杂志，2003，32（4）：333-336
22 冯钜涛，刘银坤，Mohamad RA，等. 双向电泳-质谱技术筛选肝癌血清标记物[J]. 生物化学与生物物理进展，2005，32（7）：673-677
23 King KL, Lia F, Chau GY, et al. Prognostic significance of heatshock protein 27 expression in hepatocellular carcinoma and its relationto histologic grading and survival. Cancer2000;88:2464-2470
24 Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MS profilingof serum for detection of the progression of chronic hepatitis C tohepatocellular carcinoma. Hepatology 2005;41: 634-642
25 Ai JH, Tan YX, Ying WT, et al. Proteome analysis of hepatocellularcarcinoma by laser capture microdissection. Proteomics 2006;6:538-546
26 Yokoyama Y, Kuramitsu Y, Takashima M, et al. Proteomic profilingof protein decreased in hepatocellular carcinoma from patients infectedwith hepatitis C virus. Proteomics 2004;4: 2111-2116
27 Lim SO, Park SJ, KimW, et al. Proteome analysis of hepatocellularcarcinoma. Biochem Biophys Res Commun 2002;291:1031-1037
28 Qin LX, Tang ZY. Recent progress in predictive biomarkers formetastatic recurrence of human hepatocellular carcinoma: a reviewof the literature. J Cancer Res Clin Oncol 2004;130: 497-513
29 Ding SJ, Li Y, Shao XX, et al. Proteome analysis of hepatocellularcarcinoma cell strains, MHCC972H and MHCC972L, with differentmetastasis potentials. Proteomics 2004;4: 982-994
30 Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinicalsignificance overexpression of cytokeratin 19 correlates with hepatocellularcarcinoma metastasis. Mol Cell Proteomics 2004;3:73-81
31 Vascotto C, Cesaratto L, DAmbrosio C, et al. Proteomic analysis ofliver tissues subjected to early ischemia/reperfusion injury duringhuman orthotopic liver transplantation. Proteomics,2006;6:3455-3465
32 张春潮，朱峰，尉建锋，等. 大鼠同种异体肝移植急性排异反应的蛋白质组学研究[J]. 中国科学C 辑：生命科学，2007，37（1）: 88-95
